GlassScriptPhysician profile
Comron J Hassanzadeh
NPI 1629598446
$13,894.06
in general payments reported to CMS, 2019-2025
11 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2021: $300 · 2022: $254 · 2023: $7,104 · 2024: $5,686 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,772 · Food and Beverage: $1,788 · Travel and Lodging: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,772.00 |
| Food and Beverage | $1,788.07 |
| Travel and Lodging | $1,590.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,899.47 | 2023-2024 | Spaceoar System, Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $5,548.93 | 2023-2024 | |
| Novocure INC. | $447.68 | 2021-2022 | |
| Reflexion Medical, INC. | $238.00 | 2022-2023 | Reflexion Medical Radiotherapy System |
| Telix Pharmaceuticals | $237.38 | 2023-2025 | Illuccix |
| Sirtex Medical INC | $188.93 | 2019 | |
| Janssen Biotech, INC. | $150.00 | 2025 | Erleada, Balversa |
| Mevion_medical_systems_inc | $81.63 | 2021 | |
| Ge Healthcare | $70.65 | 2025 | |
| Pfizer INC. | $31.39 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Comron Hassanzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.